This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1976 Mar;29(3):175-88.

doi: 10.1016/0021-9681(76)90044-8.

The combination of randomized and historical controls in clinical trials

PMID: 770493
DOI: 10.1016/0021-9681(76)90044-8

Review

The combination of randomized and historical controls in clinical trials

S J Pocock. J Chronic Dis. 1976 Mar.

. 1976 Mar;29(3):175-88.

doi: 10.1016/0021-9681(76)90044-8.

Author

PMID: 770493
DOI: 10.1016/0021-9681(76)90044-8

No abstract available

PubMed Disclaimer

Similar articles

Reducing the number of inferior treatments in clinical trials.
Flehinger BJ, Louis TA, Robbins H, Singer BH. Flehinger BJ, et al. Proc Natl Acad Sci U S A. 1972 Oct;69(10):2993-4. doi: 10.1073/pnas.69.10.2993. Proc Natl Acad Sci U S A. 1972. PMID: 4562750 Free PMC article. Clinical Trial.
Randomized clinical trials: design and analysis.
Green SB. Green SB. Semin Oncol. 1981 Dec;8(4):417-23. Semin Oncol. 1981. PMID: 7323813 No abstract available.
Evaluation of some strategies for treating concomitant factors in randomized trials.
Commenges D. Commenges D. Methods Inf Med. 1986 Oct;25(4):237-41. Methods Inf Med. 1986. PMID: 3773782 No abstract available.
Megaslope, natural course, and historical controls in amyotrophic lateral sclerosis trials.
Conradi S, Ronnevi LO. Conradi S, et al. Adv Neurol. 1995;68:219-24. Adv Neurol. 1995. PMID: 8787232 Review. No abstract available.
Neoadjuvant chemotherapy in invasive bladder cancer. Trial design and statistics.
Dalesio O. Dalesio O. Prog Clin Biol Res. 1990;353:57-64. Prog Clin Biol Res. 1990. PMID: 2217427 Review. No abstract available.

See all similar articles

Cited by

A diagnostic phase III/IV seamless design to investigate the diagnostic accuracy and clinical effectiveness using the example of HEDOS and HEDOS II.
Pepić A, Stark M, Friede T, Kopp-Schneider A, Calderazzo S, Reichert M, Wolf M, Wirth U, Schopf S, Zapf A. Pepić A, et al. Stat Methods Med Res. 2024 Mar;33(3):433-448. doi: 10.1177/09622802241227951. Epub 2024 Feb 7. Stat Methods Med Res. 2024. PMID: 38327081 Free PMC article. Clinical Trial.
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations.
Tan WK, Segal BD, Curtis MD, Baxi SS, Capra WB, Garrett-Mayer E, Hobbs BP, Hong DS, Hubbard RA, Zhu J, Sarkar S, Samant M. Tan WK, et al. Contemp Clin Trials Commun. 2022 Sep 20;30:101000. doi: 10.1016/j.conctc.2022.101000. eCollection 2022 Dec. Contemp Clin Trials Commun. 2022. PMID: 36186544 Free PMC article.
An Improved Matching Practice for Augmenting a Randomized Clinical Trial with External Control.
Li J, Du Y, Liu H, Yi Y. Li J, et al. Ther Innov Regul Sci. 2023 May;57(3):611-618. doi: 10.1007/s43441-023-00497-2. Epub 2023 Feb 21. Ther Innov Regul Sci. 2023. PMID: 36809484 Clinical Trial.
Assessing effects on long-term survival after early termination of randomized trials.
Shen Y, Fleming TR. Shen Y, et al. Lifetime Data Anal. 1999;5(1):55-66. doi: 10.1023/a:1009631100455. Lifetime Data Anal. 1999. PMID: 10214002
Data sources and applied methods for paclitaxel safety signal discernment.
Gressler LE, Avila-Tang E, Mao J, Avalos-Pacheco A, Shaya FT, Torosyan Y, Liebeskind A, Kinard M, Mack CD, Normand SL, Ritchey ME, Marinac-Dabic D. Gressler LE, et al. Front Cardiovasc Med. 2024 Feb 23;10:1331142. doi: 10.3389/fcvm.2023.1331142. eCollection 2023. Front Cardiovasc Med. 2024. PMID: 38463423 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions